Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Jazz Pharmaceuticals PLC
Cash from Operating Activities
Jazz Pharmaceuticals PLC
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Cash from Operating Activities
$1.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
|
Perrigo Company PLC
NYSE:PRGO
|
Cash from Operating Activities
$405.5m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-3%
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Cash from Operating Activities
-$128.5m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-20%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Cash from Operating Activities
-$33.3m
|
CAGR 3-Years
-366%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Cash from Operating Activities
€33.6m
|
CAGR 3-Years
37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
Ovoca Bio PLC
LSE:OVB
|
Cash from Operating Activities
-€1.7m
|
CAGR 3-Years
24%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
9%
|
See Also
What is Jazz Pharmaceuticals PLC's Cash from Operating Activities?
Cash from Operating Activities
1.1B
USD
Based on the financial report for Dec 31, 2023, Jazz Pharmaceuticals PLC's Cash from Operating Activities amounts to 1.1B USD.
What is Jazz Pharmaceuticals PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
14%
Over the last year, the Cash from Operating Activities growth was -14%. The average annual Cash from Operating Activities growth rates for Jazz Pharmaceuticals PLC have been 7% over the past three years , 6% over the past five years , and 14% over the past ten years .